Explore evidence

57.1 %Cumulative proportion of HBeAg seroclearance was 57.1% in patients with baseline pcG1896A mutation and 54.3% in those without, among antiretroviral-naïve HIV-HBV co-infected patients from Côte d'Ivoire.

Côte d'Ivoirehépatite Bpublished 2018Journal of viral hepatitiseurope_pmcdocument of 7 observationsDOI 10.1111/jvh.12914

4.9 per_100_person-yearsHIV incidence among regular blood donors in Abidjan decreased from 4.9 per 100 person-years in 1992–1994 to 0.07 per 100 person-years in 2010–2012.

Côte d'IvoireVIH/sidaobserved 1992–1994published 2018Open forum infectious diseaseseurope_pmcdocument of 12 observations

62.2 odds_ratioKaposi sarcoma was associated with HIV infection with an odds ratio of 62.2.

Côte d'Ivoiresarcome de Kaposi · VIH/sidapublished 2012PloS oneeurope_pmcdocument of 7 observationsDOI 10.1371/journal.pone.0048108

4,400 DALYs_per_yearThe no switch policy was predicted to lead to an overall increased number of DALYs incurred of mean 4400 per year compared with the switch policy.

Côte d'IvoireVIH/sidapublished 2025The lancet. HIVeurope_pmcdocument of 6 observations

15.9 per_100_person-yearsThe incidence of first serious event among HIV-infected adults receiving antiretroviral treatment was 15.9 per 100 person-years within the first year.

Côte d'IvoireVIH/sidapublished 2013BMC infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1186/1471-2334-13-607

The preferred treatment for cryptococcal meningitis in resource-limited countries without access to amphotericin B or 5-fluorocytosine is high-dose fluconazole (FCZ).

Côte d'Ivoireméningite cryptococciquepublished 2025IJID regionseurope_pmcdocument of 11 observations

25.7 %Among 879 participants in the Temprano randomized control trial, 226 (25.7%) had resolved hepatitis B virus infection (HBsAb-positive/HBcAb-positive).

Côte d'Ivoirehépatite Bobserved 2008 and 2015published 2021Journal of viral hepatitiseurope_pmcdocument of 5 observations

1.9 per_100_person-yearsParticipants with HBsAg and high HBV DNA had an all-cause mortality incidence of 1.9 per 100 person-years.

Côte d'Ivoirehépatite B · VIH/sidaobserved 2008 and 2015published 2021Journal of viral hepatitiseurope_pmcdocument of 5 observations

4.7 log10 copies/mLPatients in the immediate group had a median plasma HIV-1 RNA of 4.7 log10 copies/mL at baseline.

Côte d'IvoireVIH/sidapublished 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument of 8 observations

7 %Among hospitalized HIV-positive adults in West Africa who died, sepsis was a fatal disease in 7% of deaths.

Côte d'Ivoiresepsis · VIH/sidaobserved 2010published 2014Journal of the International AIDS Societyeurope_pmcdocument of 22 observationsDOI 10.7448/ias.17.1.18797

Coinfected patients with high HBV-DNA replication had significantly faster rates of CD4+ cell count increase from baseline after adjusting for baseline age, World Health Organization stage III/IV, and CD4+ cell counts.

Côte d'IvoireHIV-hepatitis B virus coinfectionpublished 2018AIDS research and human retroviruseseurope_pmcdocument of 4 observations

13.4 %During cross-sectional surveys, malaria cases prevalence ranged from 13.4% during the dry season to 43.4% in the late rainy season.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

25.9 %The main countries of infection for imported malaria cases in Tunisia were in sub-Saharan Africa, particularly the Ivory Coast (25.9%) and the Democratic Republic of Congo (24.1%).

Côte d'Ivoire · TunisiepaludismeHAL · Unilimdocument of 123 observations

219,000,000 casesGlobally in 2017, there were an estimated 219 million malaria cases.

Côte d'Ivoirepaludismeobserved 2017HAL · Unilimdocument of 122 observations

1,262 casesBetween August 31, 2016 and August 31, 2017, a total of 1262 people was tested positive for malaria in the health centres.

Côte d'Ivoirepaludismeobserved August 31, 2016 to August 31, 2017HAL · Unilimdocument of 122 observations

2,107 malaria_episodes2107 (16%) of the assessments resulted in diagnosis of a malaria episode.

Côte d'IvoirepaludismeHAL · Unilimdocument of 54 observations

24.1 %The overall prevalence of malaria cases detected by RDTs across all surveys was 24.1%.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

14.4 %In a cohort of HIV-infected patients of sub-Saharan African origin, the cumulative incidence of metabolic syndrome was 14.4% after 3 years of combined antiretroviral therapy.

Côte d'Ivoiresyndrome métabolique · VIH/sidapublished 2015AIDS research and human retroviruseseurope_pmcdocument of 7 observations

31 %Oral candidiasis was present in 31% of the HIV-infected patients.

Côte d'Ivoireoral candidiasis · VIH/sidaobserved January 2005-July 2015published 2018The Pan African medical journaleurope_pmcdocument of 9 observations

900 USDWhen the least harmful and most efficient alternatives for achieving budget cuts of 10% to 20% are applied, every year of life lost will save roughly $900 in HIV-related outlays in RSA.

Côte d'IvoireVIH/sidapublished 2017Annals of internal medicineeurope_pmcdocument of 6 observations

5.1 log10 copies/mLPatients in the deferred group who started ART had a higher median plasma HIV-1 RNA (5.1 log10 copies/mL) at baseline.

Côte d'IvoireVIH/sidapublished 2021The Journal of antimicrobial chemotherapyeurope_pmcdocument of 8 observations

19.4 %Among individuals who did not sleep under an LLIN the night before the survey, malaria prevalence was 19.4%.

Côte d'IvoirepaludismeHAL · Unilimdocument of 122 observations

4.4 %The HIV prevalence in the referent group (n=792) was 4.4% [CI 3.0-5.8].

Côte d'IvoireVIH/sidapublished 2015Cancer epidemiologyeurope_pmcdocument of 7 observations

2.67 hazard_ratioIn univariate analysis, the hazard ratio of death was 2.67 (95% CI, 1.68–4.22) for patients with HIV-1 DNA ≥3 log10 copies/million PBMC vs. others in the Temprano trial.

Côte d'IvoireVIH/sidapublished 2020EBioMedicineeurope_pmcdocument of 7 observations

8.5 %HIV incidence among female sex workers who reported not always using condoms with their clients in Côte d'Ivoire was 8.5%.

Côte d'IvoireVIH/sidaobserved 2016-2017published 2022PloS oneeurope_pmcdocument of 10 observationsDOI 10.1371/journal.pone.0271988